Premium
Inhibition of 5α‐reductase activity in human skin by zinc and azelaic acid
Author(s) -
STAMATIADIS D.,
BULTEAUPORTOIS MARIECLAIRE,
MOWSZOWICZ IRENE
Publication year - 1988
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1988.tb03474.x
Subject(s) - azelaic acid , human skin , zinc , reductase , enzyme , biochemistry , enzyme inhibitor , in vivo , chemistry , substrate (aquarium) , enzyme assay , biology , organic chemistry , ecology , genetics , microbiology and biotechnology
SUMMARY The effects of zinc sulphate and azelaic acid on 5α‐reductase activity in human skin were studied using an in vitro assay with 1,2[ 3 H]‐testosterone as substrate. When added at concentrations of 3 or 9 mmol/1, zinc was a potent inhibitor of 5α‐reductase activity. At high concentrations, zinc could completely inhibit the enzyme activity. Azelaic acid was also a potent inhibitor of 5α‐reductase; inhibition was detectable at concentrations as low as 0.2 mmol/l and was complete at 3 mmol/l. An additive effect of the two inhibitors was observed. Vitamin B6 potentiated the inhibitory effect of zinc, but not of azelaic acid, suggesting that two different mechanisms are involved. When the three substances were added together at very low concentrations which had been shown to be ineffective alone, 90% inhibition of 5α‐reductase activity was obtained. If this inhibition is confirmed in vivo , zinc sulphate combined with azelaic acid could be an effective agent in the treatment of androgen related pathology of human skin.